These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

819 related items for PubMed ID: 15738451

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.
    Diabetes Prevention Program Research GroupDiabetes Prevention Program Coordinating Center. dppmail@biostat.bsc.gwu.edu.
    Diabetes Care; 2012 Apr; 35(4):723-30. PubMed ID: 22442395
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program.
    Hernan WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, Lachin JM, Engelgau MM, Diabetes Prevention Program Research Group.
    Diabetes Care; 2003 Jan; 26(1):36-47. PubMed ID: 12502656
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of a Stepwise Approach vs Standard Care for Diabetes Prevention in India.
    Islek D, Weber MB, Ranjit Mohan A, Mohan V, Staimez LR, Harish R, Narayan KMV, Laxy M, Ali MK.
    JAMA Netw Open; 2020 Jul 01; 3(7):e207539. PubMed ID: 32725244
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H.
    Invest Clin; 1997 Mar 01; 38(1):39-52. PubMed ID: 9235072
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of metformin plus vildagliptin compared with metformin plus sulphonylurea for the treatment of patients with type 2 diabetes mellitus: a Portuguese healthcare system perspective.
    Viriato D, Calado F, Gruenberger JB, Ong SH, Carvalho D, Silva-Nunes J, Johal S, Viana R.
    J Med Econ; 2014 Jul 01; 17(7):499-507. PubMed ID: 24708176
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes.
    Ackermann RT, Marrero DG, Hicks KA, Hoerger TJ, Sorensen S, Zhang P, Engelgau MM, Ratner RE, Herman WH.
    Diabetes Care; 2006 Jun 01; 29(6):1237-41. PubMed ID: 16732002
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness and cost-effectiveness of diabetes prevention among adherent participants.
    Herman WH, Edelstein SL, Ratner RE, Montez MG, Ackermann RT, Orchard TJ, Foulkes MA, Zhang P, Saudek CD, Brown MB, Diabetes Prevention Program Research Group.
    Am J Manag Care; 2013 Jun 01; 19(3):194-202. PubMed ID: 23544761
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.